홈 > 시장보고서 > 의료기기 > 바이오장비

시장보고서

상품코드

1363037

바이러스 여과 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 기술별, 최종 용도별, 지역별, 부문별 예측(2023-2030년)

Virus Filtration Market Size, Share & Trends Analysis Report By Product, By Technology (Filtration, Chromatography), By Application (Biologicals, Medical Devices, Water Purification), By End-use, By Region, And Segment Forecasts, 2023 - 2030

발행일: 2023년 09월 | 리서치사:

Grand View Research | 페이지 정보: 영문 138 Pages | 배송안내 : 2-10일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

바이러스 여과 시장의 성장과 동향:

Grand View Research, Inc.의 새로운 보고서에 따르면 세계 바이러스 여과 시장 규모는 2030년까지 95억 달러에 달할 것으로 예상됩니다.

2023년부터 2030년까지 CAGR은 10.1%로 예측됩니다. 백신, 치료용 단백질, 혈액 및 혈액제제, 세포 및 유전자 치료제, 조직 및 줄기세포 치료제 등 생물학적 제제에 대한 수요 증가가 성장을 촉진하는 주요 요인입니다. 생물학적 제제는 주로 인간, 동물, 식물에서 유래하기 때문에 제조 시 바이러스 오염을 피하기 위해 철저한 바이러스 여과 절차를 거쳐야 합니다. 따라서 생물학적 제제 생산 시 이 절차의 필요성은 시장 성장을 촉진할 것으로 예상됩니다.

많은 대형 바이오제약 및 바이오테크놀러지 제조업체들은 혁신적인 생물학적 제제를 개발하기 위해 연구개발에 힘쓰고 있습니다. 예를 들어, 2016년 화이자는 연구개발에 78억 7,200만 달러를 투자했는데, 이는 2015년 연구개발 투자 금액보다 약 8% 더 많은 금액입니다. 이 투자는 주로 지속가능한 백신 파이프라인과 유리한 상업적 기회를 가진 차별화 된 치료법을 달성하기 위해 R&D의 혁신과 생산성을 높이기 위해 이루어졌습니다. 바이러스 여과는 생물학적 제제 개발의 중요한 단계이기 때문에 생물학적 제제에 대한 연구 개발의 증가는 제품 수요를 촉진할 것으로 예상됩니다.

바이러스 여과 시장 보고서 하이라이트

소모품 부문은 바이러스 여과를 위한 이러한 제품에 대한 수요 증가로 인해 2022년 가장 큰 매출 점유율로 시장을 장악했습니다.
크로마토그래피 기술 분야는 제품의 발전과 생물학적 제제의 R&D 및 생산 증가로 인해 예측 기간 동안 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
생물학적 제제 부문은 2022년 56.6%의 가장 큰 매출 점유율을 차지했으며, 암, 혈액 질환, 당뇨병과 같은 만성 질환의 유병률 증가로 인해 예측 기간 동안 10.9%의 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
바이오테크놀러지 및 바이오제약 기업 부문은 생물학적 제제 연구개발 및 생산에 대한 투자 증가로 인해 예측 기간 동안 가장 빠른 CAGR로 확대될 것으로 예상됩니다.
북미는 2022년 41.2%의 최대 매출 점유율로 바이러스 여과 시장을 주도했습니다. 이는 주로 여러 대형 생명공학 기업의 존재와 R&D 활동의 증가에 기인합니다.
아시아태평양은 교통사고 및 외상 증가로 인해 2023-2030년 추정 및 예측 기간 동안 CAGR 12.0%로 가장 빠르게 성장할 것으로 예상됩니다.

지역 전망
지역별 바이러스 여과 시장 : 중요한 포인트
북미
- 시장 추정과 예측, 2018-2030년
- 미국
- 캐나다
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 스웨덴
- 노르웨이
- 덴마크
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 태국
- 한국
라틴아메리카
- 브라질
- 멕시코
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제9장 경쟁 상황

주요 시장 진출 기업에 의한 최근의 동향과 영향 분석
시장 진출 기업 분류
- Merck KGaA
- Danaher
- Sartorius AG
- Thermo Fisher Scientific Inc.
- GE Healthcare
- Charles River Laboratories
- Asahi Kasei Medical Co., Ltd.
- WuXi AppTec
- Lonza
- Clean Biologics

ksm 23.11.01

Virus Filtration Market Growth & Trends:

The global virus filtration market size is expected to reach USD 9.5 billion by 2030, according to a new report by Grand View Research, Inc.. It is anticipated to register a CAGR of 10.1% from 2023 to 2030. Increasing demand for biological products such as vaccines, therapeutic proteins, blood and blood products, cellular and gene therapy, tissue, and stem cell products is a major factor driving the growth. Biopharmaceuticals are mainly derived from human, animal, and plants and therefore require a scrutinized virus filtration procedure to avoid virus contamination in the production. Therefore, the necessity of this procedure during the production of biologics is expected to boost the market growth.

Many leading biopharmaceuticals and biotechnology manufacturers are involved in R&D to develop innovative biological products. For instance, in 2016, Pfizer Inc. invested USD 7,872.0 million in R&D, which was around 8% more than the R&D investment in 2015. This investment was mainly made to boost innovation and productivity in R&D to accomplish a sustainable pipeline of vaccines and differentiated therapies with lucrative commercial opportunities. Virus filtration is an important step in biologics development, thus, increasing R&D on biologics is expected to drive the product demand.

Virus Filtration Market Report Highlights:

The consumables segment dominated the market with the largest revenue share in 2022 owing to the rising demand for these products for virus filtration.
Chromatography technology segment is expected to grow at the fastest CAGR during the forecast period, owing to product advancements and increasing R&D and production of biologics.
Biologicals segment held the largest revenue share of 56.6% in 2022 and is expected to grow at the fastest CAGR of 10.9% over the forecast period due to rising prevalence of chronic diseases such as cancer, blood disorders, and diabetes
The biotechnology and biopharmaceutical companies segment is projected to expand at the fastest CAGR over the forecast period owing to increasing investment in R&D and production of biologics
North America led the virus filtration market with the largest revenue share of 41.2% in 2022. Primarily due to the presence of several leading biotechnology companies and increased R&D activities
Asia Pacific is estimated to grow at the fastest CAGR of 12.0% over the forecast period from 2023 to 2030 due to the growing number of road accidents and trauma cases.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Technology
- 1.1.3. Application
- 1.1.4. End-use
- 1.1.5. Regional scope
- 1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Technology outlook
- 2.2.3. Application outlook
- 2.2.4. End-use outlook
- 2.2.5. Regional outlook
2.3. Competitive Insights

Chapter 3. Virus Filtration Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
3.4. Virus Filtration Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
  - 3.4.1.1. Supplier power
  - 3.4.1.2. Buyer power
  - 3.4.1.3. Substitution threat
  - 3.4.1.4. Threat of new entrant
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Technological landscape
  - 3.4.2.3. Economic landscape

Chapter 4. Virus Filtration: Product Estimates & Trend Analysis

4.1. Virus Filtration Market: Key Takeaways
4.2. Virus Filtration Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Consumables
- 4.3.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.2. Kits and reagents
  - 4.3.2.1. Kits and reagents market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.3. Others
  - 4.3.3.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Instruments
- 4.4.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.2. Filtration systems
  - 4.4.2.1. Filtration systems market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.3. Chromatography systems
  - 4.4.3.1. Chromatography systems market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Services
- 4.5.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Virus Filtration: Technology Estimates & Trend Analysis

5.1. Virus Filtration Market: Key Takeaways
5.2. Virus Filtration Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Filtration
- 5.3.1. Filtration market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.3.2. Consumables
  - 5.3.2.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.3.3. Instruments
  - 5.3.3.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.3.4. Services
  - 5.3.4.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Chromatography
- 5.4.1. Chromatography market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4.2. Consumables
  - 5.4.2.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4.3. Instruments
  - 5.4.3.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4.4. Services
  - 5.4.4.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Virus Filtration: Application Estimates & Trend Analysis

6.1. Virus Filtration Market: Key Takeaways
6.2. Virus Filtration Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Biologicals
- 6.3.1. Biologicals market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.3.2. Vaccines and therapeutics
  - 6.3.2.1. Vaccines and therapeutics market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.3.3. Blood and blood products
  - 6.3.3.1. Blood and blood products market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.3.4. Cellular and gene therapy products
  - 6.3.4.1. Cellular and gene therapy products market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.3.5. Tissue and tissue products
  - 6.3.5.1. Tissue and tissue products market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.3.6. Stem cell products
  - 6.3.6.1. Stem cell products market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Medical Devices
- 6.4.1. Medical devices market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Water Purification
- 6.5.1. Water purification market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Air Purification
- 6.6.1. Air purification market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Virus Filtration: End-use Estimates & Trend Analysis

7.1. Virus Filtration Market: Key Takeaways
7.2. Virus Filtration Market: Movement & Market Share Analysis, 2022 & 2030
7.3. Biopharmaceutical and Biotechnology Companies
- 7.3.1. Biopharmaceutical and biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Contact Research Organizations
- 7.4.1. Contact research organizations market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Medical device companies
- 7.5.1. Medical device companies market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Academic Institutes and Research Laboratories
- 7.6.1. Academic institutes and research laboratories market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Virus Filtration Market: Regional Estimates & Trend Analysis

8.1. Regional Outlook
8.2. Virus Filtration Market by Region: Key Takeaways
8.3. North America
- 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.3.2. U.S.
  - 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.3.3. Canada
  - 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4. Europe
- 8.4.1. UK
  - 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.2. Germany
  - 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.3. France
  - 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.4. Italy
  - 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.5. Spain
  - 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.6. Sweden
  - 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.7. Norway
  - 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.8. Denmark
  - 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5. Asia Pacific
- 8.5.1. Japan
  - 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.2. China
  - 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.3. India
  - 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.4. Australia
  - 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.5. Thailand
  - 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.6. South Korea
  - 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.6. Latin America
- 8.6.1. Brazil
  - 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.6.2. Mexico
  - 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.6.3. Argentina
  - 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.7. MEA
- 8.7.1. South Africa
  - 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.7.2. Saudi Arabia
  - 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.7.3. UAE
  - 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.7.4. Kuwait
  - 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Market Participant Categorization
- 9.2.1. Merck KGaA
  - 9.2.1.1. Company overview
  - 9.2.1.2. Financial performance
  - 9.2.1.3. Product benchmarking
  - 9.2.1.4. Strategic initiatives
- 9.2.2. Danaher
  - 9.2.2.1. Company overview
  - 9.2.2.2. Financial performance
  - 9.2.2.3. Product benchmarking
  - 9.2.2.4. Strategic initiatives
- 9.2.3. Sartorius AG
  - 9.2.3.1. Company overview
  - 9.2.3.2. Financial performance
  - 9.2.3.3. Product benchmarking
  - 9.2.3.4. Strategic initiatives
- 9.2.4. Thermo Fisher Scientific Inc.
  - 9.2.4.1. Company overview
  - 9.2.4.2. Financial performance
  - 9.2.4.3. Product benchmarking
  - 9.2.4.4. Strategic initiatives
- 9.2.5. GE Healthcare
  - 9.2.5.1. Company overview
  - 9.2.5.2. Financial performance
  - 9.2.5.3. Product benchmarking
  - 9.2.5.4. Strategic initiatives
- 9.2.6. Charles River Laboratories
  - 9.2.6.1. Company overview
  - 9.2.6.2. Financial performance
  - 9.2.6.3. Product benchmarking
  - 9.2.6.4. Strategic initiatives
- 9.2.7. Asahi Kasei Medical Co., Ltd.
  - 9.2.7.1. Company overview
  - 9.2.7.2. Financial performance
  - 9.2.7.3. Product benchmarking
  - 9.2.7.4. Strategic initiatives
- 9.2.8. WuXi AppTec
  - 9.2.8.1. Company overview
  - 9.2.8.2. Financial performance
  - 9.2.8.3. Product benchmarking
  - 9.2.8.4. Strategic initiatives
- 9.2.9. Lonza
  - 9.2.9.1. Company overview
  - 9.2.9.2. Financial performance
  - 9.2.9.3. Product benchmarking
  - 9.2.9.4. Strategic initiatives
- 9.2.10. Clean Biologics
  - 9.2.10.1. Company overview
  - 9.2.10.2. Financial performance
  - 9.2.10.3. Product benchmarking
  - 9.2.10.4. Strategic initiatives

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 5,950

￦ 8,443,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 6,950

￦ 9,862,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

US $ 8,950

￦ 12,700,000

※ 부가세 별도

바이러스 여과 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 기술별, 최종 용도별, 지역별, 부문별 예측(2023-2030년)

Virus Filtration Market Size, Share & Trends Analysis Report By Product, By Technology (Filtration, Chromatography), By Application (Biologicals, Medical Devices, Water Purification), By End-use, By Region, And Segment Forecasts, 2023 - 2030

바이러스 여과 시장의 성장과 동향:

바이러스 여과 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 바이러스 여과 시장 변수, 동향, 범위

제4장 바이러스 여과 : 제품 추정·동향 분석

제5장 바이러스 여과 : 기술 추정·동향 분석

제6장 바이러스 여과 : 용도 추정·동향 분석

제7장 바이러스 여과 : 최종 용도 추정·동향 분석

제8장 바이러스 여과 시장 : 지역 추정·동향 분석